Investors Snatch RARE 11.2% Cheaper Than Its Secondary Stock Offering
April 26, 2018 at 15:11 PM EDT
Looking back to 93 days ago, Ultragenyx Pharmaceutical Inc (RARE) priced a 4,385,965 share secondary stock offering at $57.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..